-- Scott Roberts
MONDAY, April 11 (HealthDay News) -- The first test to help
diagnose people with symptoms of the mosquito-borne virus dengue
fever has been approved by the U.S. Food and Drug
As many as 100 million people globally are believed infected
each year with the virus, transmitted by
Aedes mosquitoes, the FDA said in a news release. Symptoms
include high fever, severe headache and pain behind the eyes, pain
in the joints, muscles and bones, rash, and easy bleeding and
Most cases in the continental United States can be traced to
people returning from Latin America, the Caribbean and Southeast
Asia. It's also common in Puerto Rico and the Virgin Islands.
Recent dengue outbreaks have been reported in Hawaii, Texas and
Florida, the FDA said.
The DENV Detect IgM Capture ELISA test detects dengue antibodies
in the blood. The test is based on technology developed by the U.S.
Centers for Disease Control and Prevention, and is manufactured by
Inbios Inc., of Seattle.
The test should not be used in people who do not have any
symptoms of dengue fever, the FDA warned. There are no FDA-approved
vaccines to prevent the infection or medicines approved
specifically to treat it, the agency said.
The CDC has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.